Polychromatic flow cytometry identifies novel subsets of circulating cells with angiogenic potential in pediatric solid tumors

Kamnesh Pradhan, Julie A. Mund, Cynthia Johnson, Terry Vik, David Ingram, Jamie Case

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background: Pediatric solid tumors depend upon angiogenesis for their growth and metastases. A new polychromatic flow cytometry (PFC) protocol has revealed circulating cells of hematopoietic and endothelial lineages from the peripheral blood (PB) of healthy individuals, and has defined the different cell types involved in the growth of tumor vasculature that are critical in angiogenesis. Methods: PB was collected from both healthy children and children with different malignant solid tumors and the mononuclear cells (MNCs) were subsequently isolated. PFC was applied and the MNCs were evaluated for proangiogenic and nonangiogenic circulating progenitor cells (CPCs), endothelial colony forming cells (ECFCs), and mature endothelial cells using the markers CD45, CD31, AC133, CD34, CD14, CD235a, CD41a, and a viability marker. Results: ECFCs and CPCs were significantly elevated in patients at day 21 compared to controls. The ratio of proangiogenic to nonangiogenic CPCs was significantly elevated compared to controls at baseline and returned to healthy baseline levels following treatment. Conclusions: We describe the successful identification of these hematopoietic and endothelial progenitor cells in both healthy children and children with solid tumors. In addition, this is a potential discovery of novel predictive biomarkers for future clinical trials.

Original languageEnglish
Pages (from-to)335-338
Number of pages4
JournalCytometry Part B - Clinical Cytometry
Volume80 B
Issue number5
DOIs
StatePublished - Sep 2011

Fingerprint

Flow Cytometry
Pediatrics
Neoplasms
Stem Cells
Endothelial Cells
Growth
Hematopoietic Stem Cells
Biomarkers
Clinical Trials
Neoplasm Metastasis
Endothelial Progenitor Cells
Therapeutics

Keywords

  • circulating progenitor cells
  • endothelial cells
  • pediatric solid tumors

ASJC Scopus subject areas

  • Cell Biology
  • Histology
  • Pathology and Forensic Medicine

Cite this

Polychromatic flow cytometry identifies novel subsets of circulating cells with angiogenic potential in pediatric solid tumors. / Pradhan, Kamnesh; Mund, Julie A.; Johnson, Cynthia; Vik, Terry; Ingram, David; Case, Jamie.

In: Cytometry Part B - Clinical Cytometry, Vol. 80 B, No. 5, 09.2011, p. 335-338.

Research output: Contribution to journalArticle

@article{5d3aa9628323425981489ba5597792fd,
title = "Polychromatic flow cytometry identifies novel subsets of circulating cells with angiogenic potential in pediatric solid tumors",
abstract = "Background: Pediatric solid tumors depend upon angiogenesis for their growth and metastases. A new polychromatic flow cytometry (PFC) protocol has revealed circulating cells of hematopoietic and endothelial lineages from the peripheral blood (PB) of healthy individuals, and has defined the different cell types involved in the growth of tumor vasculature that are critical in angiogenesis. Methods: PB was collected from both healthy children and children with different malignant solid tumors and the mononuclear cells (MNCs) were subsequently isolated. PFC was applied and the MNCs were evaluated for proangiogenic and nonangiogenic circulating progenitor cells (CPCs), endothelial colony forming cells (ECFCs), and mature endothelial cells using the markers CD45, CD31, AC133, CD34, CD14, CD235a, CD41a, and a viability marker. Results: ECFCs and CPCs were significantly elevated in patients at day 21 compared to controls. The ratio of proangiogenic to nonangiogenic CPCs was significantly elevated compared to controls at baseline and returned to healthy baseline levels following treatment. Conclusions: We describe the successful identification of these hematopoietic and endothelial progenitor cells in both healthy children and children with solid tumors. In addition, this is a potential discovery of novel predictive biomarkers for future clinical trials.",
keywords = "circulating progenitor cells, endothelial cells, pediatric solid tumors",
author = "Kamnesh Pradhan and Mund, {Julie A.} and Cynthia Johnson and Terry Vik and David Ingram and Jamie Case",
year = "2011",
month = "9",
doi = "10.1002/cyto.b.20602",
language = "English",
volume = "80 B",
pages = "335--338",
journal = "Cytometry Part B - Clinical Cytometry",
issn = "1552-4949",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Polychromatic flow cytometry identifies novel subsets of circulating cells with angiogenic potential in pediatric solid tumors

AU - Pradhan, Kamnesh

AU - Mund, Julie A.

AU - Johnson, Cynthia

AU - Vik, Terry

AU - Ingram, David

AU - Case, Jamie

PY - 2011/9

Y1 - 2011/9

N2 - Background: Pediatric solid tumors depend upon angiogenesis for their growth and metastases. A new polychromatic flow cytometry (PFC) protocol has revealed circulating cells of hematopoietic and endothelial lineages from the peripheral blood (PB) of healthy individuals, and has defined the different cell types involved in the growth of tumor vasculature that are critical in angiogenesis. Methods: PB was collected from both healthy children and children with different malignant solid tumors and the mononuclear cells (MNCs) were subsequently isolated. PFC was applied and the MNCs were evaluated for proangiogenic and nonangiogenic circulating progenitor cells (CPCs), endothelial colony forming cells (ECFCs), and mature endothelial cells using the markers CD45, CD31, AC133, CD34, CD14, CD235a, CD41a, and a viability marker. Results: ECFCs and CPCs were significantly elevated in patients at day 21 compared to controls. The ratio of proangiogenic to nonangiogenic CPCs was significantly elevated compared to controls at baseline and returned to healthy baseline levels following treatment. Conclusions: We describe the successful identification of these hematopoietic and endothelial progenitor cells in both healthy children and children with solid tumors. In addition, this is a potential discovery of novel predictive biomarkers for future clinical trials.

AB - Background: Pediatric solid tumors depend upon angiogenesis for their growth and metastases. A new polychromatic flow cytometry (PFC) protocol has revealed circulating cells of hematopoietic and endothelial lineages from the peripheral blood (PB) of healthy individuals, and has defined the different cell types involved in the growth of tumor vasculature that are critical in angiogenesis. Methods: PB was collected from both healthy children and children with different malignant solid tumors and the mononuclear cells (MNCs) were subsequently isolated. PFC was applied and the MNCs were evaluated for proangiogenic and nonangiogenic circulating progenitor cells (CPCs), endothelial colony forming cells (ECFCs), and mature endothelial cells using the markers CD45, CD31, AC133, CD34, CD14, CD235a, CD41a, and a viability marker. Results: ECFCs and CPCs were significantly elevated in patients at day 21 compared to controls. The ratio of proangiogenic to nonangiogenic CPCs was significantly elevated compared to controls at baseline and returned to healthy baseline levels following treatment. Conclusions: We describe the successful identification of these hematopoietic and endothelial progenitor cells in both healthy children and children with solid tumors. In addition, this is a potential discovery of novel predictive biomarkers for future clinical trials.

KW - circulating progenitor cells

KW - endothelial cells

KW - pediatric solid tumors

UR - http://www.scopus.com/inward/record.url?scp=80051898442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051898442&partnerID=8YFLogxK

U2 - 10.1002/cyto.b.20602

DO - 10.1002/cyto.b.20602

M3 - Article

C2 - 21567939

AN - SCOPUS:80051898442

VL - 80 B

SP - 335

EP - 338

JO - Cytometry Part B - Clinical Cytometry

JF - Cytometry Part B - Clinical Cytometry

SN - 1552-4949

IS - 5

ER -